BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38482966)

  • 1. Surgical excision and radiotherapy for brain metastasis from colorectal cancer: How frailty and comorbidity indices influence outcome.
    Wong CE; Chang Y; Huang CC; Hsu HH; Lai YH; Chang KY; Huang CY; Wang LC; Lee JS; Lee PH
    Kaohsiung J Med Sci; 2024 Apr; 40(4):395-403. PubMed ID: 38482966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study.
    Koo T; Kim K; Park HJ; Han SW; Kim TY; Jeong SY; Park KJ; Chie EK
    Sci Rep; 2020 Mar; 10(1):4340. PubMed ID: 32152433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and prognostic factors of brain metastases from colorectal cancer: a single center experience.
    Gao Z; Jin X; Wu S
    Int J Colorectal Dis; 2023 Jul; 38(1):198. PubMed ID: 37466736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.
    Jiang XB; Yang QY; Sai K; Zhang XH; Chen ZP; Mou YG
    Tumour Biol; 2011 Dec; 32(6):1249-56. PubMed ID: 21913132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The five-item modified frailty index predicts long-term outcomes in elderly patients undergoing colorectal cancer surgery.
    Ogata T; Sadakari Y; Nakane H; Koikawa K; Kanno H; Kohata R; Endo K; Tsukahara T; Shimonaga K; Kaneshiro K; Hirokata G; Aoyagi T; Tsutsumi C; Taniguchi M
    World J Surg Oncol; 2023 Aug; 21(1):268. PubMed ID: 37626381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metastases in colorectal cancer: prognostic factors and survival analysis.
    Del Carpio Huerta L; Virgili Manrique AC; Szafranska J; Martin-Richard M; Paez Lopez-Bravo D; Sebio Garcia A; Espinosa Mariscal I; Gomila Pons P; Andres Granyo M; Barba Joaquin A; Barnadas Molins A; Tobeña Puyal M
    Int J Colorectal Dis; 2018 Nov; 33(11):1517-1523. PubMed ID: 29943356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis.
    Fuentes R; Osorio D; Expósito Hernandez J; Simancas-Racines D; Martinez-Zapata MJ; Bonfill Cosp X
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012086. PubMed ID: 30125049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastasis from colorectal cancer: clinical characteristics, timing, survival and prognostic factors.
    Quan J; Ma C; Sun P; Wang S; Zhuang M; Liu Z; Jiang Z; Chen H; Yang M; Zhao Z; Guan X; Wang X
    Scand J Gastroenterol; 2019 Nov; 54(11):1370-1375. PubMed ID: 31687871
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
    Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
    BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients.
    Gu XD; Cai YT; Zhou YM; Li ZY; Xiang JB; Chen ZY
    BMC Cancer; 2015 Nov; 15():902. PubMed ID: 26572484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
    El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
    J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
    Rades D; Hansen HC; Janssen S; Schild SE
    Anticancer Res; 2019 May; 39(5):2569-2574. PubMed ID: 31092454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole brain radiation therapy in management of brain metastasis: results and prognostic factors.
    Saito EY; Viani GA; Ferrigno R; Nakamura RA; Novaes PE; Pellizzon CA; Fogaroli RC; Conte MA; Salvajoli JV
    Radiat Oncol; 2006 Jun; 1():20. PubMed ID: 16808850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
    Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
    Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
    BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis.
    Buglione M; Pedretti S; Gipponi S; Buttolo L; Panciani P; Poliani PL; Liserre R; Borghetti P; Pegurri L; Costa L; Triggiani L; Pasinetti N; Ghirardelli P; Pandini S; Padovani A; Magrini SM;
    Radiol Med; 2015 Dec; 120(12):1146-52. PubMed ID: 25917339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib alone or with concomitant whole brain radiotherapy for patients with brain metastasis from non-small-cell lung cancer: a retrospective study.
    Zeng YD; Zhang L; Liao H; Liang Y; Xu F; Liu JL; Dinglin XX; Chen LK
    Asian Pac J Cancer Prev; 2012; 13(3):909-14. PubMed ID: 22631670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.